Multiple mechanisms underlying acquired resistance to taxanes in selected docetaxel-resistant MCF-7 breast cancer cells
about
High Bak Expression Is Associated with a Favorable Prognosis in Breast Cancer and Sensitizes Breast Cancer Cells to PaclitaxelInfluence of Matrices on 3D-Cultured Prostate Cancer Cells' Drug Response and Expression of Drug-Action Associated ProteinsThe down-regulation of SLC7A11 enhances ROS induced P-gp over-expression and drug resistance in MCF-7 breast cancer cells.Gambogic Acid lysinate induces apoptosis in breast cancer mcf-7 cells by increasing reactive oxygen species.Evidence for P-Glycoprotein Involvement in Cell Volume Regulation Using Coulter Sizing in Flow CytometryThe stepwise evolution of the exome during acquisition of docetaxel resistance in breast cancer cells.The role of Six1 signaling in paclitaxel-dependent apoptosis in MCF-7 cell line.Metabolism of the taxanes including nab-paclitaxel.Treatment regimens of classical and newer taxanes.Sensitivity of docetaxel-resistant MCF-7 breast cancer cells to microtubule-destabilizing agents including vinca alkaloids and colchicine-site binding agents.Role of delta-like ligand-4 in chemoresistance against docetaxel in MCF-7 cells.Super Aqueous Solubility of Albendazole in β-Cyclodextrin for Parenteral Application in Cancer therapy.Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers.Substituents at the C3' and C3'N positions are critical for taxanes to overcome acquired resistance of cancer cells to paclitaxel.Predicting efficacy of epirubicin by a multigene assay in advanced breast cancer within a Danish Breast Cancer Cooperative Group (DBCG) cohort: a retrospective-prospective blinded studyGenetics and Expression Profile of the Tubulin Gene Superfamily in Breast Cancer Subtypes and Its Relation to Taxane Resistance
P2860
Q28548522-02D093B5-F98F-48C2-9B82-AAB6BC16C6A6Q28552225-87873441-B6AB-4BF0-8D58-3FBFF693818DQ33812772-84F31662-EA63-443B-864D-939A5442B2C7Q35240718-DE7550BA-6894-433D-90CF-4E40E2EF199EQ35902374-F133B2F8-B10A-4BD7-9EDA-D7E6E865289EQ36045385-778E5F18-6918-4C9F-95FA-8E0CF42D0924Q36614217-706A5A2E-57D1-437C-ABAA-579A0D362D77Q38267987-F4EB8CB8-66B4-4DEE-B0C7-3851B13F05E2Q38641136-416D5BD9-06E7-4A72-B8AE-DFCE948EFECAQ38695528-2B5DBEEA-E649-464C-A9F0-AAE006F73F23Q38762728-B05942DB-98A5-4F22-B005-A787F1EA82DBQ42061069-91855950-DEC4-463A-80C3-59A36676AEADQ50847750-3CE8F472-042F-41F1-845C-856D12641689Q52602328-DFCFE361-9A2B-4B35-AC35-DE4BB6047E88Q56523625-65BFA132-06F4-4A2A-9044-9D5376FEBF5EQ58766772-10D16D18-7021-490F-A492-CD6FBCEA5FC8
P2860
Multiple mechanisms underlying acquired resistance to taxanes in selected docetaxel-resistant MCF-7 breast cancer cells
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Multiple mechanisms underlying ...... tant MCF-7 breast cancer cells
@en
Multiple mechanisms underlying ...... ant MCF-7 breast cancer cells.
@nl
type
label
Multiple mechanisms underlying ...... tant MCF-7 breast cancer cells
@en
Multiple mechanisms underlying ...... ant MCF-7 breast cancer cells.
@nl
prefLabel
Multiple mechanisms underlying ...... tant MCF-7 breast cancer cells
@en
Multiple mechanisms underlying ...... ant MCF-7 breast cancer cells.
@nl
P2093
P2860
P356
P1433
P1476
Multiple mechanisms underlying ...... tant MCF-7 breast cancer cells
@en
P2093
Amadeo M Parissenti
David N Brindley
Harris Wang
Xinmei Chen
Zhixiang Wang
P2860
P2888
P356
10.1186/1471-2407-14-37
P407
P577
2014-01-22T00:00:00Z
P5875
P6179
1027405521